Mark Murcko

Alter : 62

Vermögen : 6 579 883 USD

Wohnsitz : Unbekannt

Größte Unternehmen :

Übersicht

Mark Murcko founded Relay Therapeutics, Inc. Presently, he is Director & Chief Innovation Officer at Dewpoint Therapeutics, Inc.

He is also on the board of 9 other companies.

In the past he occupied the position of Chief Technology Officer & Vice President at Vertex Pharmaceuticals, Inc. and Senior Vice President-Strategy at Schrödinger, Inc.

He received a doctorate from Yale University.

Aktuelle Stellungen und Verantwortungsbereiche Mark Murcko

Name	Titel	Seit
Relay Therapeutics, Inc. (Biotechnologie)	Director	2018
Octant, Inc.	Director	-
Gordon Research Conferences	Trustee	-
Morphic Therapeutic, Inc.	Director	-
Quentis Therapeutics, Inc.	Director	2018
Dewpoint Therapeutics, Inc.	Director & Chief Innovation Officer	-
Quvium UK Ltd.	Director	2014
Biohybrid Solutions Holding, Inc.	Director	-
Human Immunology Biosciences, Inc.	Director	-

Anteile an Mark Murcko

Name	Aktien	%	Wert
Relay Therapeutics, Inc. (RLAY) (Biotechnologie)	996 952	0,82%	6 579 883 USD

Mark Murcko : Persönliches Netzwerk

Name	Verbundene Unternehmen
Amir H. Nashat	Dewpoint Therapeutics, Inc. Morphic Therapeutic, Inc.
Amy Schulman	Dewpoint Therapeutics, Inc. Quentis Therapeutics, Inc.
Imogen Pryce	Relay Therapeutics, Inc.
Alexis Borisy	Relay Therapeutics, Inc.
Richard A. Young	Dewpoint Therapeutics, Inc.
Olivier Brandicourt	Dewpoint Therapeutics, Inc.
Jeanne Gray	Relay Therapeutics, Inc.
Patrick Riley	Relay Therapeutics, Inc.
Andy Porter	Relay Therapeutics, Inc.
Sekar Kathiresan	Relay Therapeutics, Inc.